For equipoising donor safety and optimal recipient outcomes, we adopted an algorithmic "triangle of safety" approach to retrieve 3 types of right lobe liver grafts (RLGs), namely, the modified extended right lobe graft (MERLG), the partial right lobe graft (PRLG), and the modified right lobe graft (MRLG). Reconstruction to achieve a single wide anterior sector outflow was ensured in all patients. We present donor and recipient outcomes based on our approach in 665 right lobe (RL) living donor liver transplantations (LDLTs) performed from January 2013 to August 2015. There were 347 patients who received a MERLG, 117 who received a PRLG, and 201 who received a MRLG. A right lobe graft (RLG) with a middle hepatic vein was retrieved only in 3 out of 18 donors with steatosis >10%. Cold ischemia time was significantly more and remnant volume was less in the MRLG group. Of the donors, 29.3% had complications (26% Clavien-Dindo grade I, II) with no statistically significant difference among the groups. The Model for End-Stage Liver Disease score was higher in the MERLG group. There were 34 out of 39 with a graftto-recipient weight ratio (GRWR) of <0.7% who received a MERLG with inflow modulation. Out of 4 patients who developed small-for-size syndrome in this group, 2 died. The 90-day patient survival rate was similar among different GRWRs and types of RLG. In conclusion, a selective and tailored approach for RL donor hepatectomy based on optimal functional volume and metabolic demands not only addresses the key issue of double equipoise in LDLT but also creates a safe path for extending the limits. Medicine, Medanta-The Medicity, 14th Floor, Room Number 10, Gurgaon 122001, Delhi, India. Telephone: 01244141414-7411; FAX: +91-124 4834111; E-mail: drsanjaygoja@gmail.com Donor safety remains paramount in right lobe (RL) living donor liver transplantation (LDLT). However, an equally important goal is to ensure satisfactory graft function by having an adequate functional hepatocyte mass because the logistics and challenges of retransplantation are formidable in the LDLT setting. With the necessity of venous drainage being well established for adequate regeneration and graft function, (1) the focus in RL donation has been on parenchymal transection in relation to the middle hepatic vein (MHV) (2, 3) in a way that ensures good venous outflow in both the remnant and the graft. We have adopted a selective algorithmic approach based on donor factors (age, body mass index [BMI], and liver steatosis), venous anatomy, the remnant and graft volumes, and recipient factors like metabolic demand and portal hypertension (HTN).
Donor safety remains paramount in right lobe (RL) living donor liver transplantation (LDLT). However, an equally important goal is to ensure satisfactory graft function by having an adequate functional hepatocyte mass because the logistics and challenges of retransplantation are formidable in the LDLT setting. With the necessity of venous drainage being well established for adequate regeneration and graft function, (1) the focus in RL donation has been on parenchymal transection in relation to the middle hepatic vein (MHV) (2, 3) in a way that ensures good venous outflow in both the remnant and the graft. We have adopted a selective algorithmic approach based on donor factors (age, body mass index [BMI] , and liver steatosis), venous anatomy, the remnant and graft volumes, and recipient factors like metabolic demand and portal hypertension (HTN).
These factors were used to determine 1 of 3 types of right lobe graft (RLG) to be retrieved, namely, modified extended RLG (MERLG; segment 4aV preserving subtotal MHV), partial RLG (PRLG; division of 1 or more 4bV), and modified RLG (MRLG; segment 5 and 8 veins reconstructed). (4) Anterior sector (AS) venous outflow drainage was ensured in all patients with vascular extension grafts and reconstruction in the latter 2 to form a new MHV (neo-MHV). The aim of this study is to analyze our algorithmic approach for these 3 types of RLGs in relation to donor and recipient outcomes.
Patients and Methods
The study is a retrospective analysis of a prospectively maintained database of 665 consecutive RL LDLTs performed from January 2013 to August 2015. Three types of RLGs were retrieved based on our proposed algorithm taking all parameters into consideration (Fig. 1A,B) , with no parameters being exclusive per se. Each parameter is for (+) or against (-) MHV retrieval, thus formulating the "triangle of safety" approach ( Fig. 2) .
A MHV (+) graft means a MERLG, and a MHV (-) means a MRLG or PRLG with the selection between a MRLG and PRLG being based on venous anatomy. More than 1 negative parameter from the donor side precluded a MERLG. Negative parameters from the donor side were age > 40 years, BMI > 28 kg/m 2 , steatosis > 10%, and remnant < 32%. Highrisk points for recipients meant any of these: Model for End-Stage Liver Disease (MELD) > 25, high portal HTN, low graft-to-recipient weight ratio (GRWR), or ABO-incompatible transplant.
The primary outcomes measured were postoperative donor morbidities and 90-day patient and graft survival; secondary outcomes were other postoperative recipient outcomes. This study was approved by the institutional review board (institutional review board number MICR-782/2017). Preoperative donor and recipient selection criteria have been described elsewhere previously. (5, 6) planning tHe DOnOr HepatectOMY GRWR and the future liver remnant were estimated preoperatively on a triple-phase multidetector (MD)-computed tomography (CT) scan. The tributaries of the MHV and the dominance of the MHV or RHV in the RLG were carefully studied on a triple-phase CT scan. MHV dominance was assessed by relative size compared with the RHV and the drainage pattern was assessed on a preoperative CT scan or intraoperatively by a clamp test (if the area drained by the MHV exceeded 40%).
MHV anatomy was classified by modifying the Neumann classification into 4 types as opposed to 3 types by Neumann et al. (7) with type 4 being a mirror image of type 3 or what we call double/bifid MHV (Fig. 3A-D) . Type 1 indicated a MRLG, type 2 indicated a PRLG, and type 3 and 4 indicated a MERLG. Segment 4 venous drainage was classified as favorable or unfavorable as it shifted from predominantly into the left hepatic vein (LHV) to the proximal MHV the same as the Nakamura/Hwang classification. (8, 9) The LHV dominant (Nakamura type 1, Hwang type C, D) type was considered favorable for a MERLG, whereas a MRLG was chosen for Nakamura 3, Hwang A. A PRLG was selected for partially favorable (Nakamura 2, Hwang B) venous anatomy ( Fig. 4A-C) .
MHV tributaries were considered major if they were >5 mm, of a size easy to reconstruct, and likely to drain well, and if so, the MHV was left with the donor. Tributaries of <5 mm (up to 3 mm) were reconstructed if there were multiple, adjoined, and drained a wider area, especially of segment 5, by patch quilt venoplasty. (Fig. 5A,B) . Also bench reconstruction of veins less than 5 mm was performed in cases of marginal GRWR (<0.8), in sicker recipients, and those with high portal hypertension. Sometimes, another way to assess the necessity of drainage was during transection by clamping the vein and ipsilateral artery (with this being an absolute necessity when congestion appearing after clamping of the vein only).
We reconstructed the tributaries of the AS and all right inferior hepatic veins (RIHVs) using either a cryopreserved or an autologous portal vein (PV) graft or a nonringed expanded polytetrafluroethane (ePTFE; GORE-TEX) graft.
OperatiVe prOtOcOl

MERLG and PRLG
After RL mobilization and preserving of any RIHV of >5 mm, a cholangiogram was performed. The right hepatic artery (RHA) and right portal vein (RPV) were isolated and occluded temporarily to define the plane of transection. The liver parenchyma was transected along this plane using the Cavitron Ultrasonic Surgical Aspirator (Sonoca 400, Soring GmbH, Germany). (27) (2000); † Nakamura and Tsuzuki (8) (1981) ; Hwang et al. (9) (2005) . † † Our modification of Neumann et al. (7) (2006) classification. § Yadav et al. (5) (2017) . (B) Algorithm for MHV retrieval. *Need to reconstruct down to 3-mm veins (composite graft with patch or quilt venoplasty; Fig. 5A ,B) if recipient is at high risk. Donor negative parameters: remnant <32% (corrected for steatosis); age > 40 years; steatosis > 10%; BMI > 28 kg/m 2 (more than 1 precluded a MERLG). Recipient high-risk factors: § MELD > 25, PHTN high; GRWR < 0.8%; ABO incompatible. Anatomy: MHV and V4 anatomy.
After ligation and division of the 4b vein, dissection of the parenchyma off the MHV from all sides except its right (draining multiple segment 5 and 8 tributaries) was performed. A clamp test was done on any large tributaries from the left side before division. In the case of congestion, only a "partial" length of MHV (divided just cranial to the segment 5 vein tributary after the division of 1 or more segment 4b veins) was retrieved. A short segment of distal MHV was always kept in the donor to preserve any significant segment 4a or fissural vein draining cranially into the MHV. The remnant left lobe cut surface thus demonstrated a groove that originally housed the MHV. (4) The RHD was isolated, including the entire hilar plate using the hilar plate Glissonian sheath technique, (10) and divided. Significant RIHVs, RHAs, RPVs, MHVs, and RHVs were divided in that order, and the RLG was retrieved.
MRLG
For a MRLG, the graft retrieval technique remained the same except that dissection was continued until the union of segment 5 and segment 4b. Transection continued in the same plane, keeping the MHV on the donor side and all the tributaries of segments 5 and 8 (>3 mm diameter) in the graft preserved for reconstruction later in the bench procedure.
The graft weight was measured on the back table after flushing with cold University of Wisconsin solution (3 mL/g graft weight). MHV was extended using blood group-matched straight or Y-shaped autologous or cryopreserved PVs or ePTFE grafts to achieve a single AS outflow orifice. More than 1 RIHV requiring reconstruction, were anastomosed end to side to the lateral surface of the ePTFE conduit ("boat graft"). The neo-MHV was anastomosed to a separate venotomy in the anterior wall of the inferior vena cava in the recipient. Vascular patency was confirmed by Doppler ultrasonography following implantation. Our inflow modulation protocol is shown in Table 1 .
pOSttranSplant ManageMent
All donors were managed in the intensive care unit (ICU) on the first postoperative day. Oral intake was started on the first postoperative day. Complete blood count, liver function test, and renal function test were done daily for the first week during their hospital stay. In the follow-up period, the tests were performed twice a week until normalization and then after 1, 3, and 12 months.
Similarly, the recipients were managed in a dedicated liver transplant ICU, with a policy of early extubation, early enteral feeding, early removal of catheters and drainage tubes, and a triple-drug immunosuppressive regimen with tacrolimus, mycophenolate, and steroids tailored to the needs of individual patients.
All the recipients were followed up in a liver transplant follow-up clinic twice a week for a month, weekly for 3 months, fortnightly for 6 months, monthly for 24 months, and once in 2 months after 2 years. The follow-up was carried out by both patient visits and regular e-mail depending on the clinical condition of the patients. Small-for-size syndrome (SFSS) was defined as per the definition given by Soejima et al. (11) 
StatiStical analYSiS
Data are presented as the mean ± standard deviation (SD) for continuous variables. Continuous variables were analyzed using Student t test. Categorical variables were compared using the chi-square test. Cumulative overall survival rates were calculated using Kaplan-Meier methods, and differences between curves were evaluated using the log-rank test. A 2-tailed P value of <0.05 was considered significant. 
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All statistical data were generated using SPSS, version 20 (IBM, Chicago, IL).
Results
On the basis of our protocol, 347 patients received a MERLG, 117 received a PRLG, and 201 received a MRLG. The mean donor age was 33.06 ± 10.22 years old, and 304 were male and 361 female. Donor age, sex, and BMI were comparable among the groups (Table 2) . A total of 15 out of 18 donors with steatosis of 10%-20% on preoperative liver biopsy and 69.7% with a remnant of <32% had RLG without MHV. MERLG was retrieved in only 31.8% of donors with age >40 years and 26% of donors with BMI >28 kg/m 2 ( Table 3) .
Although graft volume was significantly more for the MERLG group, GRWR was significantly more in the recipients with a RLG without MHV. The estimated preoperative CT remnant was significantly lower in the donors in whom a RLG without the MHV was harvested.
The duration of surgery, perioperative blood loss, and hospital stay were comparable among the groups. The blood loss in our series ranged from 100 to 1000 mL. There was no donor mortality. The postoperative recovery was uneventful in 70.7% of the donors. The Clavien-Dindo (12) grade I, II, IIIa, and IIIb morbidities were seen in 18.9%, 7.1%, 1.8%, and 1.5% of the donors, respectively. Among patients with grade IIIa complications, percutaneous drainage of the nonbilious abdominal collection was the most frequent (n = 7) followed by bilious collection (n = 4). Similarly, among the IIIb complications, re-exploration for bleeding was the most common (n = 5) followed by adhesive intestinal obstruction (n = 3) and bile leak (n = 2). However, there was no statistically significant difference in grades of complication among the donors of different types of RLGs ( Fig. 6A-D .
Among the recipients, the preoperative and operative parameters as well as postoperative ICU and hospital stay lengths are shown in Table 5 . There was no significant difference among the groups in any of these parameters except cold ischemia time, which was higher among those with grafts without a MHV. Although not significant, MELD score was higher in the recipients who received a MERLG.
There were no significant differences among the groups with respect to vascular or biliary complications and early allograft dysfunction (EAD). The overall incidence of EAD was 9.9%, and the incidence of SFSS was 2.1%. Similarly, the overall incidence of re-exploration was 7.4% with intra-abdominal bleeding being the most common cause followed by hepatic artery thrombosis (Table 6) .
There were 39 patients in whom GRWR was below 0.70% intraoperatively, with the lowest being 0.55% (Table 7 ). The mean MELD score was 18, and 34 out of 39 patients received a MERLG with hemiportocaval shunt (HPCS). Their portal pressure (PP) in the dissection phase ranged from 17 to 30 mm Hg. SFSS developed in 4 patients, and 2 deaths were attributable to SFSS in this group of patients. The 90-day patient survival rate was similar among recipients with different grafts in recipients based on GRWR (Fig. 7) and types of RLG received (Fig. 8) . Bacterial sepsis (57.3%) was the most common cause of 90-day patient mortality.
Discussion
The focus of RL living donor liver procurement has been transection in relation to the MHV and a shared outflow between the AS and segment 4. Deprivation of MHV in the remnant may result in significant venous congestion in the majority of segment 4 because it drains more than 75% of it. (13) The veno-occluded region has approximately 40% of the maximum function of corresponding regions. (14) Also, the consequent impaired regeneration shifts the goalpost away from donor safety. (9, 15) 
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The RHV drains the posterior sector (PS) and sometimes the anterior superior part of the AS. (8) When the MHV is not retrieved with the RLG, the AS drainage is thus suboptimal via the RHV. The consequences are not only impaired regeneration of the AS but also immediate retrograde diversion of flow through the anterior PV and hyperperfusion of the PS. Thus, not only is there hypoperfusion of the AS but also hyperperfusion injury to the PS. (1, 16) The consequences may be immediate liver dysfunction, graft rupture, SFSS, and graft loss. (1) The preexisting intrahepatic collaterals are present in up to 20% and do not fully open until a second postoperative week, which is a long enough time for the graft to sustain an injury. (6, 17, 18) The success of the first RL LDLT by the Kyoto group (19) in 1994 and, subsequently, 25 RL LDLTs by Marcos et al. (88% patient survival) using a standard RLG (without MHV, with no reconstruction) (20) may be attributed to higher GRWR compensating for suboptimal drainage. Also, 12/25 in the series by Marcos et al. had significant RIHV (4 had 2 veins).
The evolution of the RLG shifted from a standard to an extended RLG (ERLG with the full MHV) by the Hong Kong group in 1996 on the pretext of providing greater functional liver mass to meet the metabolic demand of larger recipients. (21) A total of 26% of donors in their study had postoperative complications, which were mostly minor wound infections. But there was increased renal and hepatic dysfunction as well mortality in recipients with intra operatively occluded MHV due to technical reasons or in whom MHV was not reconstructed. There was no donor mortality. Therefore they proposed the safety and necessity of including the MHV in the graft. (18, 22, 23) Later on, the same group and others after studying segment 4 regeneration proposed tailoring RL donor hepatectomy to preserve 4a venous drainage for donor safety. (9, 15, 24) We have previously described our coring out technique of segment 4a vein, which preserves subtotal MHV retrieval. (4) Lee et al., on the pretext that ERL was a too extensive operation with a perceived higher risk for the donor, proposed a MRLG with the reconstruction of AS outflow using extension grafts. (1) They proposed the reconstruction of V5 or V8 when it was >5 mm in diameter, while also considering the liver graft size, congestion volumes, and technical feasibility of their reconstruction. Sano et al. (17) proposed a clamp test, ie, discoloration and hepatofugal portal flow upon arterial clamping of the venoccluded area, and they advised reconstruction of the hepatic vein or its tributaries if the estimated graft volume excluding the discolored area was <40% of the standard liver volume. 
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The Kyoto group (2) proposed a graft selection algorithm based on GRWR (with 1 as the cutoff ), percentage of liver remnant (with 35% as the cutoff ), and estimated congestion ratio (0.4 as the cutoff ). de Villa et al. (3) described the Kaohsiung principle for selecting the graft type based on the GRWR, (1) the volume of the donor's RL to the recipient's standard liver volume (40%), and the size of the MHV tributaries (5 mm) from the anterior segment.
We propose an algorithm for 3 types of RLGs depending on the variable length of the retrieved MHV based on the triangular approach of metabolic and regeneration demand, volumes, and venous anatomy.
The first goal for the donor is to keep the MHV with a remnant to avoid any further congestive injury whenever there is either a greater need or factors affecting regeneration in the remnant. At the same time, for recipients with high MELD (≥25), high portal HTN, and low GRWR (<0.8%), the preferred graft is with the MHV to ensure good and uniform outflow avoiding partial congestion in any segment, thus preventing SFSS. Our algorithmic protocol of graft selection for NOTE: Data are given as n or n (%). the particular donor-recipient pair has yielded comparable postoperative outcomes in both. Predominant segment 4 venous drainage in either the LHV or the MHV is an important determinant in graft selection (8, 9) as is MHV anatomy. (7) Greater variability in the drainage pattern is usual in segments 4a and 5, whereas it is less variable in 8 and 4b. The MHV (segment 5) drains 8%-13% of segment 6 because of its extensive branching pattern. (7, 13) Therefore, segment 5 drainage was ensured in all patients because it also avoids congestion in the suprahilar area, which may jeopardize biliary reconstruction.
The low remnant volume is a key determinant for developing postoperative complications and SFSS in living donors. (25) Although the critical value of the remnant liver volume (RLV) of 27% came from nondonor hepatectomy data, (26) for an increased margin of donor safety, it was extended to 30%. (27) NOTE: Data are given as n (%) and mean ± SD. a strict selection criteria-preservation of the MHV, age < 50 years, and no or mild fatty changes-which showed equivalent outcomes in the remnant of <30%, with the lowest being 23%. (28) The International Liver Transplantation Society Guidelines set the RLV limit at 30%-35%. (29) From all available data, the fact remains that as RLV goes down, MHV preservation in the remnant becomes the policy. Our cutoff is 32% for the RLG without the MHV, which was harvested in 70% of the donors whose remnant was between 30% and 32%. Age does not seem to significantly affect liver function although there is a reduction in size and a decline in blood flow. There are contradicting studies of recipient outcomes using older donors with some showing no difference, whereas others showed higher complications, SFSS, and mortality. However, the well-documented effect of aging is the impairment of liver regeneration due to various molecular mechanisms. (30) Ono et al. (31) used a magnet-activated cell-sorting technique and observed that the progenitor cell population (Thy-1+CD90) consistently tended to decline with age in LDLT. Donor liver regeneration assessed at day 7 by CT volumetry was significantly higher in donors aged <30 years old than those >50 years old. There are reports of donor age as a significant factor affecting postoperative liver functioning. (32) Disease severity is a significant factor that determines graft outcomes, (30) and MELD score has been used to quantify the severity of recipient disease objectively. A study of 1000 consecutive LDLT recipients from the same institution showed that outcomes of high MELD (≥25) recipients were comparable to those of patients with a low MELD (<25) score when GRWR was >0.8% and good AS drainage by MHV was ensured. (5) In our study, only 31.8% of donors >40 years old donated a MERLG, and 62.2% of the recipients with high MELD received a MERLG.
Most centers, including our own center, limit the acceptance of RL liver donors with hepatic steatosis up to 20%, (27) although Marcos et al. (33) extended it up to 30% on biopsy.
Evidence for impaired liver regeneration in donors with significant steatosis comes from an animal model of partial hepatectomy (34) and a retrospective human study of major hepatic resections. (35) Moderate-tosevere hepatic steatosis was associated with an increased postoperative morbidity, mortality, transfusion requirement, and surgical time. (35) Reduced microcirculation due to reduced hepatic sinusoidal space and increased susceptibility of steatotic hepatocytes to ischemia/ reperfusion injury has been attributed as the main factors leading to hepatic parenchymal injury in patients with a fatty liver. (36) Thus, parenchymal congestion in the remnant may be worsened when the MHV is taken with the graft in fatty livers. (37) Accurate detection and quantification of hepatic fat are essential not only for determining the potential donor's eligibility but also in graft selection. Previous studies have shown a positive correlation between hepatic steatosis and BMI. (38) Rinella et al. (39) found 30% of donors with a BMI of 25-28 kg/m 2 and 70% with a BMI above 28 kg/m 2 had steatosis on biopsy with a significant correlation between BMI and the grade of steatosis, whereas 30% of patients in the magnetic resonance imaging group and 24% in the CT group failed to show steatosis when it was present on biopsy. In a similar study, 75% of donors in the 4th quartile of BMI (23.48-29 kg/m 2 ) had steatosis, out of which 70% had >10% steatosis. (37) Our cutoff for donor acceptance is a BMI of 34 kg/ m 2 , and donors with a BMI of >28 kg/m 2 are assessed by biopsy. We prefer non-MHV grafts in donors with a BMI of >28 kg/m 2 and steatosis of >10% (83%).
A GRWR of <0.8%-1.0% or <30%-50% of standard/estimated liver volumes have been used to define Original article | 1375 become the single most important factor in preventing SFSS and in using extended criteria donors.
In conclusion, our triangle of safety approach to the length of the retrieved MHV not only addresses the key issue of donor safety and the optimal recipient outcomes but also stands out as a safer policy for use of extended RL donations in LDLT. reFerenceS small-for-size grafts in previous reports. (40, 41) At the present time, some institutes have established criteria for graft selection with a lower GRWR than before. For either a GRWR of >0.8% (42) or of >0.6% in combination with portal venous pressure (PVP) control, (43) the set safety limit depends on the original disease and the clinical status of the recipient and duration of pretransplant deterioration. (40) Similarly, a GRWR of 0.8%, although a standard cutoff, (44) may not totally hold the key to preventing SFSS. An elevated PVP (>20 mm Hg) after LDLT has been shown to be closely associated with morbidity and poor graft prognosis. (45) Ogura et al. (46) demonstrated that a PVP <15 mm Hg is associated with good patient outcomes in a retrospective clinical analysis, ie, patients with a PVP of <15 mm Hg demonstrated a better 2-year survival (93.0%) than patients with a PP of ≥15 mm Hg (66.3%). Thus, as the severity of portal hypertension (PHTN) holds the key to preventing SFSS, inflow modulation and good outflow become a must (Table 7) . A RL with the MHV is optimal for physiological drainage to avoid any congested areas that could seriously impair the total functional capacity of marginal small-for-size grafts in marginal recipients.
In the present study, as the GRWR increased, the number of MERLGs decreased. All recipients with GRWR 0.55%-0.59%, 86% of patients with GRWR of 0.60%-0.70%, and 73% of patients with GRWR of 0.70%-0.74% received a MERLG. At the same time, the policy was to perform inflow modulation based on a PP cutoff of ≤15 mm Hg. There were 4 patients with GRWR 0.55%-0.59%, and HPCS was done in all patients with none developing SFSS. However, 4 out of 35 (11.4%) patients with GRWR 0.60%-0.69% developed SFSS, and 2 died of the same reason despite HPCS.
The limitations of the present study are the retrospective nature and the lack of posttransplant sectorial regeneration volume data in both the donors and the recipients. However, in our series, none of the donors and only 2.1% of the recipients developed SFSS. Therefore, conducting a CT contrast study to know the regeneration in the presence of good functional recovery especially in donors would always be difficult to justify ethically.
In summary, our algorithmic approach and thus the proposed triangle of safety (Fig. 2) for the different types of RLGs sets the best match for a particular donor and recipient pair with comparable donor and recipient outcomes across different RLG types. This becomes more important as GRWR decreases and portal dynamics
